Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase
Clinical trial NCT00481052 · COMPLETED
Trial details
- NCT number
- NCT00481052
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-23
- Primary completion
- 2018-04-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.